Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

219
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
219
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

3.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.2K
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

222
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
222
Bioequivalence: Overview01:16

Bioequivalence: Overview

1.6K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.6K
Pharmacovigilance01:19

Pharmacovigilance

1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

155
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
155

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The Timed Up and Go Test in Patients with Haemophilia: Assessing Reliability, Validity, and Predictive Variables.

Hamostaseologie·2025
Same author

Immunoinflammatory response in periodontal diseases.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2025
Same author

Long-term cryopreservation of dental stem cells.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2023
Same author

Varicocelectomy improves sperm parameters, sperm DNA integrity as well as the other critical semen features.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2023
Same author

Genomic testing for copy number and single nucleotide variants in spermatogenic failure.

Journal of assisted reproduction and genetics·2022
Same author

The Preperitoneal Space in Hernia Repair.

Frontiers in surgery·2022

相关实验视频

Updated: Jan 9, 2026

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

1.7K

生物制药:重要性,应用,功能 - - 一个叙述性的回顾.

R Brozek1, A Lorenz, B Dorocka-Bobkowska

  • 1Department of Prosthodontics and Geriatric Dentistry, Poznan University of Medical Sciences, Poznan, Poland. kurpimac@man.poznan.pl.

European review for medical and pharmacological sciences
|December 4, 2025
PubMed
概括

针对Janus Kinase/信号转换器和转录激活器 (JAK/STAT) 和核因子kappa B (NF-κB) 途径的生物制药为自身免疫和炎症性疾病提供了向治疗. 了解这些途径有助于开发新的治疗方法,例如牙周炎.

科学领域:

  • 免疫学 免疫学 免疫学
  • 分子生物学分子生物学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 生物制药是调节生物体过程的生物活性物质,通常模仿天然蛋白质或与细胞受体相互作用.
  • 由于它们的结构和有针对性的作用机制,它们具有很高的治疗特异性.
  • 简氏激酶/信号转换器和转录激活器 (JAK/STAT) 和核因子kappa B (NF-κB) 信号通路的失调与各种疾病有关.

研究的目的:

  • 提出调节JAK/STAT和NF-κB信号通路的生物制药.
  • 探索这些通路在自身免疫性,瘤性,血液性,皮肤性,类风湿性和口腔疾病 (包括牙周炎) 中的作用.
  • 通过了解这些分子机制,突出开发向治疗的潜力.

主要方法:

  • 对针对JAK/STAT和NF-κB信号的生物制药机制的审查.
  • 分析这些途径在疾病发病过程中的作用.
  • 对针对性抑制的治疗影响的讨论.

主要成果:

  • 生物制药可以有效调节JAK/STAT和NF-κB通路.
  • 这些途径在许多炎症和瘤疾病的发病过程中至关重要.
  • 这些通路的信号干扰可能导致牙周炎等口腔疾病.

更多相关视频

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.5K
Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
10:50

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

15.2K

相关实验视频

Last Updated: Jan 9, 2026

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

1.7K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.5K
Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
10:50

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

15.2K

结论:

  • 向抑制JAK-STAT和NF-κB通路提供了一个有前途的治疗策略.
  • 了解这些信号级联有助于开发一系列疾病的新疗法.
  • 修改宿主分子反应可能会在与现有治疗相结合时提供显著的治疗益处.